MétaCan
Menu
Back to cohort
Record W3089607491 · doi:10.1158/1538-7445.mel2019-a18

Abstract A18: Ccn1 expression by fibroblasts is required for melanoma metastasis

2020· article· en· W3089607491 on OpenAlexaff
James Hutchenreuther, Katherine Quensel, Krista M. Vincent, Lynne-Marie Posrovit, Andrew Leask

Bibliographic record

VenueCancer Research · 2020
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicConnective Tissue Growth Factor Research
Canadian institutionsUniversity of AlbertaWestern University
Fundersnot available
KeywordsCancer researchMetastasisCYR61MelanomaExtracellular matrixTumor microenvironmentTumor progressionPathologyBiologyMatricellular proteinCancerCTGFMedicineGrowth factorCell biology

Abstract

fetched live from OpenAlex

Abstract Metastatic melanoma is highly fatal. Within the tumor microenvironment, the role of cancer-associated fibroblasts (CAFs) in melanoma metastasis and progression is relatively understudied. Matricellular proteins of the CCN family are emerging targets for cancer therapy. Anti-CCN2 (CTGF) strategies are under clinical development; however, the role of CCN1 (cyr61) in cancers is unclear. Herein, we use bioinformatic analyses to report that the CCN1 is overexpressed, in a fashion independent of BRAF mutational status, in melanoma. In human melanoma patients, CCN1 expression negatively correlates with overall survival, disease-free, and metastasis-free survival (p<0.03). CCN1 expression positively correlates with expression of stroma and neovascularization markers. To assess the role of CAFs in melanoma progression, we used C57BL/6 mice expressing a tamoxifen-dependent cre recombinase expressed under the control of a fibroblast-specific promoter/enhancer (COL1A2) to delete CCN1 postnatally in fibroblasts. Mice deleted or not for CCN1 in fibroblasts were injected subcutaneously with B16-F10 melanoma cells. Loss of CCN1 in CAFs did not result in reduced CAF activation, as detected by staining with anti-α-smooth muscle actin antibodies, but resulted in reduced extracellular matrix surrounding tumors, as detected by trichrome stain, and reduced tumor-induced neovascularization, as detected by staining with anti-CD31 antibodies. CCN1-deficient skin showed reduced expression of mRNAs encoding collagen crosslinking enzymes (PLOD2 and LOX) and impaired formation of collagen fibers, as determined by electron microscopy. Tumor growth was not affected by loss of CCN1 from tumor stroma; however, micrometastasis to the lung was severely impaired (p<0.001). Our results provide new insights into the crosstalk among different cell types in the tumor microenvironment and confirm the essential role of CAFs in metastasis and tumor neovascularization. Our data are consistent with the hypothesis that CAFs are essential for melanoma metastasis and that CCN1 is a therapeutic target for melanoma. Citation Format: James Hutchenreuther, Katherine Quensel, Krista Vincent, Lynne-Marie Posrovit, Andrew Leask. Ccn1 expression by fibroblasts is required for melanoma metastasis [abstract]. In: Proceedings of the AACR Special Conference on Melanoma: From Biology to Target; 2019 Jan 15-18; Houston, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(19 Suppl):Abstract nr A18.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.115
GPT teacher head0.415
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicConnective Tissue Growth Factor ResearchFrench-language works237,207